The most frequent issues were nausea , vomiting, diarrhea, abdominal pain, and constipation
This article examines how each medicine works, what is currently known about their combined use, the potential risks involved, and why specialist medical guidance is essential before considering either agent
UK Evidence and Guidance Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with comorbidities
doi: 10.14218/JCTH.2016.00009 106 LiuYLPatmanGLLeathartJBPiguetACBurtADDufourJFet al
Dosage Frequency Most injectables are taken once a week, while oral options are daily
Some people don't think the bill goes far enough to restore rights, but it's a step in the right direction, she said